EA202193278A1 - MEDICINE FOR THE PREVENTION AND/OR TREATMENT OF BEHAVIORAL AND PSYCHOTIC SYMPTOMS ASSOCIATED WITH A NEURODEGENERATIVE DISEASE OR IMPULSITY SYMPTOMS ASSOCIATED WITH MENTAL DISEASE, CONTAINING BREXPIPRAZOLE OR THE SALT OF ITS - Google Patents

MEDICINE FOR THE PREVENTION AND/OR TREATMENT OF BEHAVIORAL AND PSYCHOTIC SYMPTOMS ASSOCIATED WITH A NEURODEGENERATIVE DISEASE OR IMPULSITY SYMPTOMS ASSOCIATED WITH MENTAL DISEASE, CONTAINING BREXPIPRAZOLE OR THE SALT OF ITS

Info

Publication number
EA202193278A1
EA202193278A1 EA202193278A EA202193278A EA202193278A1 EA 202193278 A1 EA202193278 A1 EA 202193278A1 EA 202193278 A EA202193278 A EA 202193278A EA 202193278 A EA202193278 A EA 202193278A EA 202193278 A1 EA202193278 A1 EA 202193278A1
Authority
EA
Eurasian Patent Office
Prior art keywords
symptoms associated
behavioral
prevention
salt
treatment
Prior art date
Application number
EA202193278A
Other languages
Russian (ru)
Inventor
Синдзи Сато
Кендзи Маеда
Даи Исикава
Маи Накамура
Original Assignee
Оцука Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Оцука Фармасьютикал Ко., Лтд. filed Critical Оцука Фармасьютикал Ко., Лтд.
Publication of EA202193278A1 publication Critical patent/EA202193278A1/en

Links

Abstract

Настоящее изобретение относится к средству для профилактики и/или лечения поведенческих и психотических симптомов, связанных с нейродегенеративным заболеванием, или симптомов импульсивности, связанных с психическим заболеванием, которое содержит 7-[4-(4-бензо[b]тиофен-4-ил-пиперазин-1-ил)бутокси]-1H-хинолин-2-он или его соль в качестве активного ингредиента.The present invention relates to an agent for the prevention and/or treatment of behavioral and psychotic symptoms associated with a neurodegenerative disease, or impulsive symptoms associated with mental illness, which contains 7-[4-(4-benzo[b]thiophen-4-yl- piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof as an active ingredient.

EA202193278A 2013-03-14 2013-10-24 MEDICINE FOR THE PREVENTION AND/OR TREATMENT OF BEHAVIORAL AND PSYCHOTIC SYMPTOMS ASSOCIATED WITH A NEURODEGENERATIVE DISEASE OR IMPULSITY SYMPTOMS ASSOCIATED WITH MENTAL DISEASE, CONTAINING BREXPIPRAZOLE OR THE SALT OF ITS EA202193278A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361782467P 2013-03-14 2013-03-14

Publications (1)

Publication Number Publication Date
EA202193278A1 true EA202193278A1 (en) 2022-02-07

Family

ID=80631337

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202193278A EA202193278A1 (en) 2013-03-14 2013-10-24 MEDICINE FOR THE PREVENTION AND/OR TREATMENT OF BEHAVIORAL AND PSYCHOTIC SYMPTOMS ASSOCIATED WITH A NEURODEGENERATIVE DISEASE OR IMPULSITY SYMPTOMS ASSOCIATED WITH MENTAL DISEASE, CONTAINING BREXPIPRAZOLE OR THE SALT OF ITS

Country Status (1)

Country Link
EA (1) EA202193278A1 (en)

Similar Documents

Publication Publication Date Title
EA201590808A1 (en) MEANS FOR PREVENTION AND / OR TREATMENT OF BEHAVIORAL AND PSYCHOLOGICAL HEADLOOKING CAMERATOUS CENTRAL APPLICATIONS HOME APPLICATION CURRENT SPECIALIZED CURRENT OUTDOSE CONDITIONS
EA201491933A1 (en) DIHYDRATE COMPOUND OF BENZOTHIOPHENE OR ITS SALT AND METHOD OF ITS OBTAINING
EA201991484A1 (en) MEDICINAL FORMS OF ENZALUTAMIDE
UA116648C2 (en) FUMARATS AS A PRODUCT AND THEIR USE IN THE TREATMENT OF DIFFERENT DISEASES
BR112015002524A2 (en) alkylpyrimidine derivatives for the treatment of viral infections and other diseases.
BR112015032693A2 (en) bromodomain inhibitors
EA201591166A1 (en) AUTOTAXIN INHIBITORS
EA201591003A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
EA201591616A1 (en) TRIFTTOROMETHYL-SUBSTITUTED ANNELATED PYRIMIDINES AND THEIR APPLICATION
EA201690372A1 (en) AZAPIRIDON COMPOUNDS AND THEIR APPLICATION
EA201391033A1 (en) BACE-2 INHIBITORS FOR THE TREATMENT OF METABOLIC DISORDERS
GEP20166554B (en) Nitrogenated heterocyclic compound
EA201500383A1 (en) DERIVATIVES 1,2,4-TRIAZINE FOR THE TREATMENT OF VIRAL INFECTIONS
EA201400976A1 (en) BENZODIOXANES IN COMBINATION WITH OTHER ACTIVE MEANS TO INHIBIT LEUKOTRIEN PRODUCTION
EA201690371A1 (en) PYRIDAZINOUS COMPOUNDS AND THEIR APPLICATION
EA201690039A1 (en) RORC2 INHIBITORS AND METHODS OF THEIR APPLICATION
EA201791219A1 (en) ANTIBACTERIAL COMPOSITIONS HAVING A WIDE ACTIVITY SPECTRUM
EA201591698A1 (en) MACRO CYCLIC INHIBITORS OF KINASE LRRK2
EA201690783A1 (en) SUBSTANCES, PHARMACEUTICAL COMPOSITION AND METHODS OF APPLICATION IN THE TREATMENT OF INFLAMMATORY DISEASES
EA201501187A1 (en) NEW CHEMICAL COMPOUNDS (OPTIONS) AND THEIR APPLICATION FOR THE TREATMENT OF CANCER DISEASES
UY34843A (en) TREATMENT OF OCULAR INFLAMMATORY DISEASES USING LAQUINIMOD
EA201691108A1 (en) Quinazoline-THF-Amines as PDE1 Inhibitors
CL2015003431A1 (en) Pyridone derivatives for the treatment of viral infections and additional diseases
EA201600002A1 (en) DERIVATIVES OF SUBSTITUTED TRIAZOLOPIRIDINES
EA201500232A1 (en) Three (hetero) arylpyrazoles and their use